VHB Life Sciences Limited manufactures Letrozole Tablets. VHB Life Sciences Limited has WHO GMP certified facility as well as INVIMA approved facility. Letrozole Tablets are available in packing of three blisters of ten tablets. It is used in first-line treatment of postmenopausal women with hormone-receptor positive or hormone-receptor unknown locally advanced or metastatic breast cancer and second-line treatment of postmenopausal women with advanced breast cancer after progression on tamoxifen therapy. The brand name of these tablets is Letzol.
